A. Consolazio
Research Subjects
A. Consolazio has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Domenico Ferro
Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Policlinico Umberto 1, Sapienza University, 00161 Rome, Italy
1 shared publication F. Iacopini
Department of Clinical Sciences, Gastroenterology Unit, Rome
1 shared publicationF. Nardi
Department of Pathology
1 shared publicationM. C. Borgia
Department of Clinical Sciences, Gastroenterology Unit, Rome
1 shared publicationM. Rivera
Department of Clinical Sciences, Gastroenterology Unit, Rome
1 shared publication- Omero Alessandro Paoluzi
Department of Systems Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy
1 shared publication
Latest Publications
- 15 July 2004
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (3) , 289-294
Increased thrombin generation and circulating levels of tumour necrosis factor‐α in patients with chronic Helicobacter pylori‐positive gastritis
Summary: Background : Conflicting data have been reported concerning the relationship between Helicobacter pylori infection and coronary heart disease.Aim : To evaluate clotting system activation and plasma levels of tumour necrosis factor‐α, a procoagulant cytokine, in patients with H. pylori‐positive and ‐negative gastritis.Methods : Three groups of patients were identified: 38 with H. pylori‐positive gastritis, 18 with H. pylori‐negative gastritis, and 40 H. pylori‐negative controls with normal gastric mucosa. Plasma levels of prothrombin fragment 1 + 2 (F1 + 2) and tumour necrosis factor‐α were assayed. Patients were also controlled after 2 and 6 months following standard H. pylori eradication treatment.Results : At baseline, fragment 1 + 2 and tumour necrosis factor‐α levels in H. pylori‐positive patients were significantly higher than those in H. pylori‐negative patients with gastritis (P < 0.05 and P < 0.01, respectively). After H. pylori eradication, fragment 1 + 2 and tumour necrosis factor‐α levels showed a significant decrease at 2 months (P = 0.03 and P = 0.02, respectively) and a further reduction at 6 months, reaching levels observed in H. pylori‐negative patients and controls.Conclusions : The increase thrombin generation rate and the correlation of plasma fragment 1 + 2 and tumour necrosis factor‐α levels in H. pylori‐positive patients suggest a role for inflammation in mediating the relationship between H. pylori infection and activation of the clotting system.
- 15 July 2004
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (3) , 289-294
Increased thrombin generation and circulating levels of tumour necrosis factor‐α in patients with chronic Helicobacter pylori‐positive gastritis
Summary: Background : Conflicting data have been reported concerning the relationship between Helicobacter pylori infection and coronary heart disease.Aim : To evaluate clotting system activation and plasma levels of tumour necrosis factor‐α, a procoagulant cytokine, in patients with H. pylori‐positive and ‐negative gastritis.Methods : Three groups of patients were identified: 38 with H. pylori‐positive gastritis, 18 with H. pylori‐negative gastritis, and 40 H. pylori‐negative controls with normal gastric mucosa. Plasma levels of prothrombin fragment 1 + 2 (F1 + 2) and tumour necrosis factor‐α were assayed. Patients were also controlled after 2 and 6 months following standard H. pylori eradication treatment.Results : At baseline, fragment 1 + 2 and tumour necrosis factor‐α levels in H. pylori‐positive patients were significantly higher than those in H. pylori‐negative patients with gastritis (P < 0.05 and P < 0.01, respectively). After H. pylori eradication, fragment 1 + 2 and tumour necrosis factor‐α levels showed a significant decrease at 2 months (P = 0.03 and P = 0.02, respectively) and a further reduction at 6 months, reaching levels observed in H. pylori‐negative patients and controls.Conclusions : The increase thrombin generation rate and the correlation of plasma fragment 1 + 2 and tumour necrosis factor‐α levels in H. pylori‐positive patients suggest a role for inflammation in mediating the relationship between H. pylori infection and activation of the clotting system.